SCHEMBL20039961

SCHEMBL20039961

CCOC(=O)CCCCC(=O)c1ccc(C)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
NPC1 O15118 1/20 0.53
HSD17B3 P37058 7/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
HPGD P15428 1/20 0.49
CYP4F2 P78329 1/20 0.49
CYP4A11 Q02928 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
ABL1 P00519 1/20 0.48
HTT P42858 1/20 0.48
RIN1 Q13671 1/20 0.48
CTNNB1 P35222 1/20 0.47
WNT3A P56704 1/20 0.47
GSK3B P49841 1/20 0.47
CYP1A2 P05177 1/20 0.47
LMNA P02545 1/20 0.47
HTR7 P34969 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13784599 0.98 HSD17B3 (0.51) KMT2ANPC1HSD17B3L3MBTL1ALDH1A1
SCHEMBL2743316 0.97 NPC1 (0.57) KMT2ANPC1HSD17B3L3MBTL1ALDH1A1
SCHEMBL10749473 0.89 KMT2A (0.61) KMT2ANPC1L3MBTL1ALDH1A1MAPT
SCHEMBL1360326 0.87 HTR7 (0.65) KMT2ANPC1HSD17B3L3MBTL1ALDH1A1
SCHEMBL10950721 0.87 KMT2A (0.54) KMT2ANPC1HSD17B3L3MBTL1ALDH1A1
SCHEMBL9442288 0.87 CA12 (0.54) KMT2ANPC1HSD17B3L3MBTL1ALDH1A1
SCHEMBL5147538 0.86 L3MBTL1 (0.63) KMT2ANPC1L3MBTL1ALDH1A1MAPT
SCHEMBL7460876 0.85 KMT2A (0.53) KMT2ANPC1HSD17B3L3MBTL1ALDH1A1
SCHEMBL7457718 0.85 KMT2A (0.53) KMT2ANPC1HSD17B3L3MBTL1ALDH1A1
SCHEMBL9308927 0.85 PDE4B (0.62) KMT2ANPC1L3MBTL1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3091012-B1 CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF CENTREXION THERAPEUTICS CORP (US) 2018-04-11 EP disclosed